Roche, Warp Drive Launch Up-to-$387M Natural Antibiotics Collaboration
Roche will partner with Warp Drive Bio to develop new classes of antibiotics against multi-drug-resistant bacterial infections, through a collaboration that will generate up-to-$387 million-plus for Warp Drive, the Cambridge, MA-based biotech said today.The partnership is designed to advance “multiple” novel classes of natural antibiotics that show activity against clinically important, drug-resistant, Gram-negative pathogens by applying Warp Drive’s Genome Mining™ platfo
Read more »